Product Information
LEVONORGESTREL 1.5 MG TABLET is a generic product labeled by Xiromed LLC, priced at $6.3305 per EA under NDC 70700016406. Its NADAC has been published 328 times since Jun 24, 2020.
FDA first approved this application on Sep 18, 2018.
Strength
1.5 mg/1
Manufacturer
Xiromed LLCNDC
70700016406
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LEVONORGESTRELApproval Type
Generic (ANDA)
FDA Application
ANDA205329FDA Approved
9/18/2018
On Market Since
3/13/2020
Pharmacological Classes
Price Statistics
The NADAC for LEVONORGESTREL 1.5 MG TABLET has been published 328 times since Jun 24, 2020, and over the history we have for it it has declined 33.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.3305 per EA |
|---|---|
| All-time high | $10.4571 (Jan 13, 2021) |
| All-time low | $5.2568 (Nov 20, 2024) |
| 52-week high | $6.8109 |
| 52-week low | $6.2162 |
| Median price | $7.0509 |
| Average price | $7.7846 |
| Largest weekly change | -18.7% (Nov 20, 2024) |
| Weeks tracked | 328 |
| Tracking since | Jun 24, 2020 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Xiromed LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levonorgestrel market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Progestin class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVONORGESTREL 1.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVONORGESTREL 1.5 MG TABLET, manufactured by Xiromed LLC, is $6.3305 per EA (NDC 70700016406), effective Sep 30, 2026.
How has the price of LEVONORGESTREL 1.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVONORGESTREL 1.5 MG TABLET has declined 33.6%. It has been tracked across 328 weekly CMS publications since Jun 24, 2020.
What are the highest and lowest recorded NADAC prices for LEVONORGESTREL 1.5 MG TABLET?
Since Jun 24, 2020, the NADAC for LEVONORGESTREL 1.5 MG TABLET has ranged from a low of $5.2568 (Nov 20, 2024) to a high of $10.4571 (Jan 13, 2021), with a median of $7.0509 per EA.
Are there cheaper alternatives to LEVONORGESTREL 1.5 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LEVONORGESTREL 1.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LEVONORGESTREL 1.5 MG TABLET?
LEVONORGESTREL 1.5 MG TABLET (NDC 70700016406) is labeled by Xiromed LLC, and CMS classifies it as a generic product.